Drugstore chain Walgreen's quarterly sales rise 6.2 percent
Reuters
Published Sep 30, 2014 07:52AM ET
Drugstore chain Walgreen's quarterly sales rise 6.2 percent
(Reuters) - U.S. drugstore chain operator Walgreen Co reported a 6.2 percent rise in quarterly sales, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading.
Prescription sales, which made up nearly two thirds of the company's total sales, rose 9.3 percent in the fourth quarter ended Aug. 31.
Total revenue rose to $19.06 billion in the quarter from $17.94 billion a year earlier.
The net loss attributable to the company was $239 million, or 25 cents per share, in the quarter, and included an $866 million non-cash loss due to the amendment and exercise of its Alliance Boots call option.
Walgreen posted a profit of $657 million, or 69 cents per share, a year earlier.
Excluding items, the company earned 74 cents per share in the latest quarter.
The company's shares rose 3.2 percent to $61.50 in trading before the bell on Tuesday.
(Reporting by Nandita Bose in Chicago and Sruthi Ramakrishnan in Bangalore; Editing by Savio D'Souza)
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.